BNBX
Applied DNA Sciences, Inc.
NASDAQ: BNBX · FINANCIAL SERVICES · ASSET MANAGEMENT
$0.13
+48.11% today
Updated 2026-07-29
Market cap
$2.72M
P/E ratio
0.00
P/S ratio
1.30x
EPS (TTM)
$370.17
Dividend yield
—
52W range
$0 – $7
Volume
0.3M
Applied DNA Sciences, Inc. (BNBX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.13
12-Month target
$1,920.25
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.